Conor Stewart
Research expert covering health & pharmaceuticals in the UK & Europe
Get in touch with us now| Characteristic | Influenza* | Tdap** |
|---|---|---|
| - | - | - |
| - | - | - |
| - | - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Download
Source
Sources
Release date
October 2020
More information
Region
United States
Survey time period
April 2 to 14, 2020
Number of respondents
2,268 respondents
Age group
18-49 years
Special properties
Women pregnant during the peak influenza vaccination period (October 2019–January 2020)
Method of interview
Online survey
Supplementary notes
* Women pregnant any time during October 2019–January 2020 were included in the analyses to assess influenza vaccination coverage for the 2019–20 season.
Women who received an influenza vaccination since July 1, 2019, before or during their pregnancy were considered vaccinated.
** Tdap- tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccination. Women pregnant any time since August 1, 2019, and who had a live birth were included in the analysis to assess Tdap coverage. Women who received a Tdap
vaccination during their recent pregnancy were considered vaccinated.
Citation formats
